Press Release
The unique community-driven decentralized trading platform in the TECO ecosystem-TDEX

With the rapid development of the globalization of the encryption industry, countries and regions have higher and higher requirements for practitioners. Technology drives industry innovation. International policies, and the introduction and supervision of national laws and regulations drive the birth of a new generation of products.
TDEX is one of them. Because the TECO ecosystem is no longer affected by centralized institutions, the TECO ecological decentralized trading platform TDEX came into being. According to official news, TDEX will be launched in the near future. TDEX is initiated by the TECO overseas community. It is committed to serving the users of the TECO global ecological community and creating a new generation of decentralized exchanges that are truly built for the future of the TT community. It is to promote the TECO global community. A very important step in entering DAO autonomy.

The bottom layer of TDEX is based on: 1. Security of assets (decentralized wallet TECO), 2. Fairness of rules (smart contracts), 3. Diversification mechanism, 4. DAO organization. Truly return to decentralization, and give users in the global community a truly safe, transparent, fair, and ecological place organized by the DAO.
It is worth mentioning that DEX has two major technological innovations. One is the pure contract version of the order-assisted transaction, which has significant advantages in transaction speed and transaction depth compared with Xswap. The second is that TDEX is a native DAPP with user experience in trading. Smoother. In addition, TDEX has also opened a new transaction mining model, where transactions and pending orders are mining, so that investors and traders can achieve a win-win situation under this economic model.
As the representative of TDEX’s overseas operations team said, “No matter from its birth background, development layout, technical characteristics, or diversified trading mechanism, the future value of TDEX is immeasurable”.
TECO DAPP download link:https://storage.teco.cool/teco/web/index.html
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Interest in Indoor Playgrounds Jumps 44% in Philadelphia as November Arrives
Searches for indoor playgrounds climb as soon as the cold arrives, a pattern Playspace by Kidology also sees with families at its two locations.
Philadelphia, Pennsylvania, United States, 5th Nov 2026 — Every year, Playspace by Kidology sees families head indoors as the cold arrives. While reviewing search trends as part of its seasonal marketing research, the team found that the same shift shows up clearly online. According to search data from Ahrefs, a search research platform, searches for “indoor playground philadelphia” run 37% above their yearly average in November and keep climbing through the season: 19% above average in December, 66% above in January and still 14% to 17% above in February and March. From April to September, the same searches fall 12% to 36% below average.

Google Trends shows the same pattern over a longer period. Across the past five years in the Philadelphia area, interest in “indoor playground” has been about 44% higher in November than in October, and it has reached its highest point between December and February every winter.
The timing follows the weather. Average highs in Philadelphia drop from about 56°F in November to about 40°F in January, the coldest month of the year, with average lows in the mid-20s. The pattern is national too: searches for “indoor playground near me” average about 44,000 a month in the U.S. and reach their highest point in January, 27% above average.
“We see it every year at our own front door: as soon as the cold sets in, more families come in looking for somewhere warm where their little ones can climb, run and burn off energy,” said Luba Patlakh Kaplun, founder of Kidology. “When we looked at the search data, it showed the same thing, and it starts earlier than many people think. Winter is long in Philadelphia, and for parents of toddlers and young kids, an indoor playground is one of the easiest ways to keep active play in the week, whatever the weather.”
What the numbers mean for Philadelphia families
- Winter planning starts in November, not January. Local searches for indoor playgrounds are already 37% above average in November. Families who line up their cold-weather outings now have a plan before the January peak.
- Birthday party venues are booked early. Nationally, searches for kids’ birthday party venues run 49% above average in November and 58% above in January, so winter and spring party dates go quickly.
- Indoor play isn’t only a winter thing. There is a second, smaller rise in summer: searches for indoor activities for kids are 30% above average in July, when the heat keeps families inside.
About Playspace by Kidology
Playspace by Kidology is an indoor playground for children from birth to 12, with locations in Northeast Philadelphia and Southampton, Bucks County. Kids climb rock walls, go down slides and play in sensory-friendly spaces. The playground is also available for birthday party rentals and play gift cards are available for the holidays.
For more information, visit kidologyplayspaces.com
Media Contact
Organization: Playspace by Kidology
Contact Person: Luba Patlakh Kaplun
Website: https://kidologyplayspaces.com/
Email: Send Email
Contact Number: +12153304116
Address: 928 Jaymor Rd c150, Southampton, PA 18966
Address 2: 2800 Southampton Rd, Philadelphia, PA 19154
City: Philadelphia
State: Pennsylvania
Country: United States
Release id: 50488
View source version on King Newswire:
Interest in Indoor Playgrounds Jumps 44% in Philadelphia as November Arrives
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Maylene Showcases Its Best-Selling Research Peptides with UK-Wide Delivery
Research-use catalogue combines prefilled formats, clear product specifications and supporting documentation, with free delivery across the United Kingdom.
United Kingdom, 5th Nov 2026 – Maylene is putting the spotlight on its best-selling research peptide range, giving laboratory buyers access to an online catalogue backed by UK dispatch, clearly displayed pricing and available product documentation.

The Maylene platform brings together research peptides, individual compound listings and educational resources in one place. Visitors can explore available products, compare labelled strengths and review format and pack information before placing an order.
With free UK-wide delivery, Maylene offers a convenient purchasing option for laboratory buyers who value accessible product information and straightforward ordering. Its catalogue includes individual compounds, blends and bundles, allowing customers to browse different options according to their research requirements.
Featured Compounds Across the Maylene Range
Maylene’s featured selection includes BPC-157, GHK-Cu, retatrutide and compound blends, giving laboratory buyers a range of research-use options to explore. Each listing clearly presents the product name, labelled content, format and price, making it easier to compare specifications and review available supporting documentation before ordering.
This presentation gives customers a practical basis for comparison. Rather than relying on a product name alone, visitors can review the stated strength, check the selected pack and examine any supporting records available for that product.
For buyers exploring multiple options, dedicated collections make it easier to navigate the catalogue and move between individual listings. Product bundles are also presented separately, helping visitors distinguish a single item from a combined purchase.
Prefilled Research Formats in One Collection
The Maylene peptide pen collection brings together prefilled single-compound and blend products. Listings identify labelled content and pack quantities so laboratory buyers can compare available formats with greater clarity.
The distinction between individual content and total pack content is particularly useful when reviewing multipacks. A pack containing two pens has a different specification from a single pen carrying the same combined total. Maylene’s product information allows visitors to check those details before purchasing.
Blend listings also provide composition information, giving buyers a way to review the individual compounds within a product rather than relying only on its combined labelled strength.
All products in the collection are supplied for laboratory and research purposes only.
Product Documentation Available for Review
Alongside its catalogue, Maylene provides access to published laboratory reports where available. Customers can review these records and check whether the documentation corresponds to the product and strength they intend to purchase.
Maylene explains that published reports relate to the samples tested. They do not verify every batch in stock, and report coverage is not available for every product. Buyers should therefore check the documentation relevant to their exact item and contact the team where further clarification is needed.
Making these distinctions visible gives customers a more useful basis for evaluating product information. Labelled specifications, published records and batch details each serve a different purpose and should be considered together.
Free UK Delivery and Direct Support
Maylene offers free delivery across the United Kingdom, with products dispatched from the UK and tracking information provided after dispatch. International shipping is also available, with delivery details presented on the website.
Customers can review ordering information before completing a purchase, including their selected product, pack quantity and total. For questions about available documentation, product specifications or the ordering process, Maylene provides direct support through its listed contact channels.
This combination of UK fulfilment and accessible support gives laboratory buyers a clear route from browsing the catalogue to resolving product-specific enquiries.
Research Resources Beyond the Catalogue
Maylene’s website also features educational guides and compound information, providing additional context for visitors exploring its range. These resources sit alongside the commercial catalogue, allowing buyers to review background information while checking individual product specifications.
The platform brings together catalogue navigation, research reading and available documentation without changing the products’ stated purpose. Educational material does not establish suitability for human use or replace the assessments required for a laboratory’s own work.
Maylene invites laboratory buyers to explore its featured range, compare available formats and review the relevant product information before ordering.
About Maylene
Maylene supplies research-use products dispatched from the United Kingdom. Its online catalogue includes individual compounds, prefilled research pens, blends and bundles, supported by educational resources and available laboratory documentation. The company offers free UK delivery and international shipping options.
Research-Use Notice
All products sold by Maylene are intended solely for laboratory and research purposes. They are not intended for human or veterinary use, consumption or application. Product descriptions and educational resources do not constitute medical advice.
Media Contact
Organization: Maylene
Contact Person: Sam Aquino
Website: https://www.maylene.uk/
Email: Send Email
Country: United Kingdom
Release id: 50483
View source version on King Newswire:
Maylene Showcases Its Best-Selling Research Peptides with UK-Wide Delivery
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Together We Build Iraq Mayes Ali Hadi Al-Hassany’s Journey from the Laboratory to a Vision for Iraqi-Made Medicines
From a land shaped by ancient civilisations, Iraqi researcher Mayes Ali Hadi Al-Hassany brings together pharmaceutical science, project management and technology. She has a clear goal for investors to get behind: building factories in Iraq that make medicines patients can trust and supply them to markets across the region.
Iraq, 5th Nov 2026 – Together We Build Iraq Mayes Ali Hadi Al-Hassany’s Journey from the Laboratory to a Vision for Iraqi-Made Medicines – Together, we build Iraq. Imagine a pharmacist in Amman or Dubai reaching for a box marked “Made in Iraq.” Behind that box are researchers who developed its formulation, technicians who mastered its production, and a laboratory that verified its quality before it left the factory. This is the scene Mayes Ali Hadi Al-Hassany wants to see become part of Iraq’s future.

Returning to the Classroom
Mayes Al-hassany began her career in pharmacy and went on to pursue research in pharmaceutical science and manufacturing. After gaining experience in the field, she stepped away from pharmacy practice for a time and returned to the classroom to study project management. She wanted to learn how to secure funding for a scientific idea, build the team to carry it out, and use promising laboratory results to make a case for manufacturing to investors.
She attended several international conferences, kept up with developments in Western pharmacy markets, and studied the business models of retailers such as Australia’s Chemist Warehouse, Britain’s Boots and Watsons. What caught her attention was the work behind the shelves. Even before a factory buys its first piece of equipment, demand, product availability and distribution can help determine which medicines are worth making and in what quantities.
From Pharmaceutical Research to the Factory Floor
Mayes Al-hassany completed a series of studies in pharmaceutical science and manufacturing and published her work internationally. Her research included developing a formulation for extended-release metformin tablets and comparing its drug-release profile with that of a reference product. She also studied the stability of amlodipine tablets under hot and humid conditions to understand how formulation and packaging affect the quality of the medicine during storage.
She discussed her work with academics and researchers from universities and research centres in several countries. Some of those who reviewed her studies and discussed them with her expressed admiration for her work. They saw her ability to connect laboratory questions with manufacturing challenges as a sign of what she could contribute to pharmaceutical science in the years ahead.
That connection shapes her vision for Iraqi manufacturing. She wants an Iraqi factory to begin with a carefully chosen product, a team that knows how to maintain its quality, and a system that can trace every batch. Once the factory demonstrates consistent quality and reliable supply, it can pursue registration and distribution in neighbouring markets in line with local requirements.
A Call to Iraqi Investors
Mayes Al-hassany’s message to investors is clear. Invest in pharmaceutical factories in Iraq and in the people who will run and improve them. A single production line backed by a sound feasibility study can give Iraqi researchers a place to put their knowledge to work at home, young technicians a chance to gain industrial experience, and patients access to locally made medicines they can trust.
For Mayes Al-hassany, pride in Iraq’s heritage finds expression in the path she has chosen. She wants to put her knowledge to work for others and bring the questions she learned to ask in the laboratory to the factory floor. When a box of Iraqi-made medicine reaches a pharmacy beyond the country’s borders, the achievement worth celebrating will be the work behind it: the people who turned scientific knowledge into a medicine someone could depend on.
Media Contact
Organization: HQearth
Contact Person: Mayes Ali Alhassany
Website: https://www.hqearth.org/
Email: Send Email
Country: Iraq
Release id: 50485
View source version on King Newswire:
Together We Build Iraq Mayes Ali Hadi Al-Hassany’s Journey from the Laboratory to a Vision for Iraqi-Made Medicines
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release5 days ago
A Better Life Through Ai Wheel Mobility Scooter 20 inch Boarding Luggage: Airwheel Smart Carry on hand Luxury Cabin Suitcase Shine at the 140th Canton Fair
-
Press Release5 days ago
Soika Labs Launches Mockingjay Network, an Agentic AI Operating System That Lets Businesses Command Their Own AI Workforce
-
Press Release6 days ago
AIXONA Announces AI-Powered Transaction Optimization and Expansion into European and Canadian Markets
-
Press Release1 week ago
FinSight Ventures Launches $100 Million Physical AI Index Fund
-
Press Release1 week ago
Alex Cecola Highlights Why Investment Process Matters More Than Market Prediction for Long- Term Investors
-
Press Release5 days ago
Remittances to Uzbekistan Reach $18.9bn as OSON X Opens a UAE Money App for Central Asians
-
Press Release5 days ago
Aussie Vape Trend Scales Wholesale Supply Network Across Australia
-
Press Release5 days ago
Rossi Paola Vargas Daly Connects Public Health Research and Criminal Law
